Skip to main content
BYON Co., Ltd. logo

BYON Co., Ltd. — Investor Relations & Filings

Ticker · 032980 ISIN · KR7032980005 KO Wholesale and retail trade
Open in API
Filings indexed 483 across all filing types
Latest filing 2025-07-30 Declaration of Voting R…
Country KR South Korea
Listing KO 032980

About BYON Co., Ltd.

http://www.byon.kr

BYON Co., Ltd. is a diversified company engaged in the manufacture and sale of industrial chemicals and materials. The company also operates a biomedical division focused on biopharmaceutical development, including cell therapy using stem cell technology for applications such as the commercialization of myocardial cells. Additional business segments include cosmetics and the development of health-related raw materials, such as red ginseng.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company 'Bion'. It details the resolutions passed, including the appointment of directors, changes to the articles of incorporation, and capital reduction (share consolidation). This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-07-30 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing CEO, the incoming CEOs (Park Beom-jin and Park Jeong-han), the reason for the change, the date of the board resolution, and the professional backgrounds of the new appointees. This aligns perfectly with the definition for Board/Management Information (MANG).
2025-07-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board and management changes.
2025-07-30 Korean
경영권변경등에관한계약체결
M&A Activity Classification · 100% confidence The document is a regulatory filing regarding a 'Change in Management Control' (경영권 변경 등에 관한 계약 체결). It details a contract between the current majority shareholder and a new party (Park Beom-jin) involving management participation, capital injection, and board changes. This type of corporate event disclosure is a standard regulatory filing in the Korean market, and since it does not fit into specific categories like M&A (which usually implies a full takeover or merger) or Board Changes (which is a result of this contract, not the contract itself), it is best classified as a general Regulatory Filing (RNS).
2025-07-29 Korean
기타시장안내 (상장적격성 실질심사 사유추가 안내)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ market regarding the addition of a 'substantive review of listing eligibility' (상장적격성 실질심사) for the company Bion. It is a formal regulatory announcement concerning market status and compliance, which does not fit into specific categories like financial reports or M&A, making it a standard regulatory filing.
2025-07-29 Korean
[기재정정]기타시장안내 (상장적격성 실질심사 사유추가 안내)
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement from the KOSDAQ market regarding the addition of grounds for a substantive review of listing eligibility for the company 'Bion'. It is a short, formal regulatory notice concerning market status and compliance, which fits the definition of a general regulatory filing that does not fall into specific categories like financial reports or shareholder meetings.
2025-07-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.